Forian Inc
NASDAQ:FORA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Forian Inc
Additional Paid In Capital
Forian Inc
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Forian Inc
NASDAQ:FORA
|
Additional Paid In Capital
$82.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Additional Paid In Capital
$2.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
24%
|
CAGR 10-Years
23%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Additional Paid In Capital
$927.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Additional Paid In Capital
$894.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
127%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Additional Paid In Capital
$1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Additional Paid In Capital
$4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Forian Inc
Glance View
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 138 full-time employees. The company went IPO on 2021-03-03. The firm provides software solutions, data and predictive analytics to optimize the operational, clinical and financial performance of its healthcare, cannabis, and government customers. Its BioTrack vertically integrated point-of-sale, manufacturing, delivery and cultivator software solution is a commercial platform in the cannabis industry, serving dispensaries, cultivators, manufacturers and distributors within 38 states and Puerto Rico. Its Cannalytics software as a service (SaaS)-based analytics solution is a platform that provides clients with a configurable and flexible presentation of business performance. Its real world experience (RWE) solutions are designed to enable the integration otherwise unconnected and disparate data to enable near real-time surveillance of adverse events and to study the clinical economic and social impacts of various therapeutic alternatives, including those derived from cannabinoids and psychedelics.
See Also
What is Forian Inc's Additional Paid In Capital?
Additional Paid In Capital
82.5m
USD
Based on the financial report for Dec 31, 2025, Forian Inc's Additional Paid In Capital amounts to 82.5m USD.
What is Forian Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
36%
Over the last year, the Additional Paid In Capital growth was 3%. The average annual Additional Paid In Capital growth rates for Forian Inc have been 5% over the past three years , 36% over the past five years .
